We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Distribution Agreement for MRI Analysis Tools to Evaluate Neurologic Disorders

By HospiMedica International staff writers
Posted on 20 Dec 2010
Newly designed software is intended for automatic labeling, visualization, and volumetric quantification of segmentable brain structures from a set of magnetic resonance (MR) images.

Invivo (Pewaukee, WI, USA), a developer and manufacturer of MRI clinical solutions, announced an agreement with CorTechs Labs, Inc. More...
(La Jolla, CA, USA), to be the key distributor for the NeuroQuant product in the US marketplace. NeuroQuant will augment the DynaSuite Neuro Solution from Invivo by providing enhanced diagnostic capabilities to healthcare practitioners that may help in the assessment of patients with Alzheimer's disease, epilepsy, and other neurologic disorders.

DynaSuite Neuro by Invivo provides a platform to help transition advanced neuro applications and functional MRI from the research environment to the day-to-day clinical practice. It offers the workflow and productivity that allow radiologists to perform advanced neuro analysis. By incorporating the NeuroQuant application, neurologists, radiologists, and clinical researchers can now use DynaSuite Neuro to quantify the volume of the hippocampus and other neuro structures.

NeuroQuant takes high-resolution, three-dimensional (3D) T1-weighted, sagittal, non-contrast-enhanced MRI scans and automatically processes the large amount of data for easy physician review. It returns a new, full-volume spatially corrected and anatomically labeled dataset with two printable patient reports containing the absolute and relative volumes of the hippocampus, temporal horn, and other structures. The new, integrated diagnostic solution comes at an increasingly important time for the early detection of Alzheimer's disease and other disorders.

"We are excited about the NeuroQuant partnership and expanding the capabilities of DynaSuite Neuro. It is consistent with our strategy to extend our leadership position in advanced Neuro Solutions," said Michael Kapp, product manager for neuro solutions at Invivo. "Invivo is delighted to offer this product by CorTechs Labs as it complements our existing portfolio."

According to Michael Smith, president of CorTechs Labs, "It was extremely important for to us to identify a partner that shares the same goals as our company and has the ability to provide customers with a first class service, support, and distribution network. Invivo clearly fits the criteria we identified to promote our innovative solution for diagnostic imaging facilities."

Related Links:
Invivo
CorTechs Labs



Gold Member
Neonatal Heel Incision Device
Tenderfoot
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Syringe Pump
SP50 Series
Resorbable Bovine Collagen Membrane
GenDerm
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.